Glucagon Production: Key Insights on Who Produces the Glucagon Peptide
Published: July 22, 2026 14:55
Author: Julia Herrera
Abstract: Glucagon, a 29-amino acid peptide, is primarily produced by pancreatic alpha-cells. Key manufacturers include Novo Nordisk and Eli Lilly, leveraging recombinant DNA technology for high-purity GLP-1 analogs. Market trends show 12.3% CAGR (2023-2030) driven by diabetes and obesity applications. Brand comparisons highlight Lilly’s superior stability vs. Novo’s cost-efficiency. Regulatory certifications (FDA, EMA) ensure quality. Logistics require cold-chain (-20°C) to maintain bioactivity. Industry insights emphasize peptide purity (>98%) and scalable GMP facilities for competitive advantage.